Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020

SELL
$4.66 - $8.7 $686,660 - $1.28 Million
-147,352 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$5.05 - $15.01 $1.75 Million - $5.2 Million
-346,387 Reduced 70.16%
147,352 $889,000
Q4 2019

Feb 13, 2020

BUY
$6.32 - $19.66 $813,630 - $2.53 Million
128,739 Added 35.27%
493,739 $6.86 Million
Q3 2019

Nov 14, 2019

BUY
$8.03 - $14.82 $240,899 - $444,600
30,000 Added 8.96%
365,000 $3.06 Million
Q2 2019

Aug 14, 2019

BUY
$11.88 - $16.94 $1.31 Million - $1.86 Million
110,000 Added 48.89%
335,000 $0
Q1 2019

Jun 20, 2019

BUY
$17.44 - $17.95 $3.92 Million - $4.04 Million
225,000 New
225,000 $4.04 Million

Others Institutions Holding DTIL

About PRECISION BIOSCIENCES INC


  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $604M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.